IDERA & DESIGN

View On IC.GC.CA

REGISTERED

on 26 Jul 2019

Last Applicant/ Owned by

IDERA PHARMACEUTICALS INC.

167 Sidney StreetCambridge, MA 02139

Serial Number

1761948 filed on 5^th Jan 2016

Registration Number

TMA1044998 registered on 26^th Jul 2019

Registration expiry Date

26^th Jul 2029

Correspondent Address

KIRBY EADES GALE BAKER

55 Murray StreetSuite 300Ottawa

ONTARIO

K1N5M3

IDERA & DESIGN

Trademark usage description

medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nucleic acids as biologically active immune modulators, bio Read More

Vienna Information

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information

Class [005]
Medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nucleic acids as biologically active immune modulators, biologically active antisense DNA and ribonucleic acid (RNA) compounds, chemical modulators of gene expression, namely reagents for DNA transcription, ribonucleic acid (RNA) and translation processes whereby a protein is synthesized from the information contained in a molecule of messenger RNA (mRNA); immunomodulatory oligonucleotides, namely, ingredients that enhance and induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral infections, bacterial infections, inflammatory disorders and inflammatory diseases, namely, anti-infectives and anti-inflammatories; pharmaceuticals for use in the treatment of asthma and allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection and diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents and cellular genes.

Classification kind code

Class [042]
Medical research; scientific research in the field of genetics and genetic engineering; biological research in the field of genetics and genetic engineering; chemical research; medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development for others; biological and chemical research in the field of immunology.

Classification kind code

Mark Details

Serial Number

1761948

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 27^th Sept 2018	Approved
Submitted for opposition 130 on 29^th Aug 2018	Note to file
Submitted for opposition 27 on 10^th Aug 2018	Approval Notice Sent
Submitted for opposition 15 on 14^th Dec 2017	Correspondence Created
Submitted for opposition 12 on 10^th Apr 2017	Extension of Time
Submitted for opposition 22 on 21^st Sept 2016	Search Recorded
Submitted for opposition 20 on 21^st Sept 2016	Examiner's First Report
Submitted for opposition 31 on 8^th Jan 2016	Formalized
Submitted for opposition 1 on 6^th Jan 2016	Created
Submitted for opposition 30 on 5^th Jan 2016	Filed